New multilocus sequence typing scheme for Enterococcus faecium reveals sequential outbreaks of vancomycin-resistant

Masaki Karino1,2,3, Masashi Yanagihara1, Tetsuya Harada4

  • 1Department of Clinical Laboratory and Biomedical Sciences, Laboratory of Medical Microbiology and Microbiome, Division of Health Sciences, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Microbiology Spectrum
|December 10, 2024
PubMed

Insights

The Bezdíček multilocus sequence typing (MLST) scheme effectively tracks hospital-acquired vancomycin-resistant Enterococcus faecium (VREfm) infections. This new scheme offers high discriminatory power, comparable to pulsed-field gel electrophoresis (PFGE), making it a practical clinical tool.

Area of Science:

  • Clinical microbiology
  • Infectious disease epidemiology
  • Molecular typing

Background:

  • Vancomycin-resistant Enterococcus faecium (VREfm) is a significant cause of hospital-acquired infections.
  • Effective molecular tools are essential for controlling VREfm transmission.
  • Pulsed-field gel electrophoresis (PFGE) is limited by equipment availability, necessitating alternative methods.

Purpose of the Study:

  • To evaluate the clinical utility of the new Bezdíček multilocus sequence typing (MLST) scheme for analyzing nosocomial VREfm transmission.
  • To compare the Bezdíček MLST scheme with the original MLST scheme and PFGE.

Main Methods:

  • Compared PFGE, original MLST, and Bezdíček MLST schemes using 68 VREfm isolates from a Japanese hospital outbreak.
  • Analyzed genetic similarity and discriminatory power using Simpson's index of diversity.
  • Integrated Bezdíček MLST data with admission records for outbreak visualization.

Main Results:

  • PFGE identified nine clusters; the original MLST scheme identified five sequence types (STOs), with STO192 predominant.
  • The Bezdíček scheme identified nine sequence types (STBs), subdividing STO192 and showing higher discriminatory power (0.648) than the original scheme (0.317).
  • Combining Bezdíček MLST with admission records provided clearer visualization of sequential outbreaks caused by distinct STBs.

Conclusions:

  • The Bezdíček MLST scheme demonstrates high discriminatory power comparable to PFGE for VREfm.
  • Its standardization and global availability make it a practical alternative for clinical laboratories.
  • The Bezdíček scheme facilitates effective control of nosocomial VREfm infections by improving outbreak analysis.